Georgios DrakakisInformation Technology (IT)
BSc Computer Science, Aristotle University of Thessaloniki; MSc Computer Science, Trinity College Dublin; MSc Advanced Biological Sciences, University of Liverpool, PhD in Cheminformatics, University of Cambridge
Dr. Drakakis is currently the CEO of the in silico drug repurposing company Purposeful. He has worked as a research associate for 2.5 years at the National Technical University of Athens and for 1 at the University of Cambridge, after obtaining the EPSRC Doctoral Prize. Dr. Drakakis joined the Department of Information Technology at the American College of Greece in September 2018. He is currently teaching the Machine Vision course for the MS in Data Science.
His research interests include machine learning, data mining, cheminformatics, computational chemistry and machine vision. Over the past 5 years he has co-authored 12 original research publications in these fields and contributed to 2 book chapters.